Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday. The agency, along with maker Novo Nordisk, confirmed that supply now meets or exceeds both the current ...

Trulicity (dulaglutide) is a prescription drug that can cause weight loss in some people but is not approved for this use.

Adults with type 2 diabetes may have a higher risk for developing nonarteritic anterior ischemic optic neuropathy while using ...

Expected out-of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...

The use of semaglutide (Ozempic) was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in ...

Expected out of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D beneficiaries as drug plans increasingly tie patient costs to list prices, ...

Expected out of-pocket costs for commonly prescribed brand name medications have grown substantially for Medicare Part D ...

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Other GLP1-RA include the compounds dulaglutide and liraglutide. These contain active ingredients such as semaglutide and dulaglutide and are considered an advancement in weight management and the ...

The research-ready Virtual Registry was built as part of the Helix Research Network (HRN). The cohort consists of whole Exome+® sequencing profiles for 15,000 GLP-1 agonist treat ...

dulaglutide and many others. The research-ready Virtual Registry was built as part of the Helix Research Network (HRN). The cohort consists of whole Exome+ ® sequencing profiles for 15,000 GLP-1 ...